Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome.

MLA

Patti, Giuseppe, et al. “Prevalence and Predictors of Dual Antiplatelet Therapy Prolongation beyond One Year in Patients with Acute Coronary Syndrome.” PloS One, vol. 12, no. 10, Oct. 2017, p. e0186961. EBSCOhost, https://doi.org/10.1371/journal.pone.0186961.

APA

Patti, G., Cavallari, I., Antonucci, E., Calabrò, P., Cirillo, P., Gresele, P., Palareti, G., Pengo, V., Pignatelli, P., Ricottini, E., & Marcucci, R. (2017). Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome. PloS One, 12(10), e0186961. https://doi.org/10.1371/journal.pone.0186961

Chicago

Patti, Giuseppe, Ilaria Cavallari, Emilia Antonucci, Paolo Calabrò, Plinio Cirillo, Paolo Gresele, Gualtiero Palareti, et al. 2017. “Prevalence and Predictors of Dual Antiplatelet Therapy Prolongation beyond One Year in Patients with Acute Coronary Syndrome.” PloS One 12 (10): e0186961. doi:10.1371/journal.pone.0186961.